7th Genome Editing Therapeutics Summit
4 4 people viewed this event.
The FDA has shown its’ hand. The Plausible Mechanism Framework and new NGS safety guidance signal one thing clearly: regulators want genome editing therapies to reach patients.
Time: 8:00 AM – 5:00 PM
Venue details: Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Speakers: Devyn Smith, Chief Executive Officer, Arbor Biotechnologies, Kyle Watters, Director, Precision Editing, Arbor Biotechnologies, and more
Event Organizer: Hanson Wade